contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


redeye-bico-q4-review-improving-outlook-and-trades-at-less1x-sales

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.

Bico Group Audiocast Q3’25:                   Inderes              BICO, Audiocast, Q3'25 - Inderes    Time: 2025-11-04 10:00 Language: en Language: en Sector: Health care - Pharmaceuticals & Biotechnology Activity: Audiocast with teleconference

Mattek og Visikol solgt for 80 mio. $ til 4x salgspris. Jeg gider ikke lige at finde ud af, hvad der blev betalt for disse, men det lyder godt. Det har godt nok været noget af et rod, denne virksomheds rejse fra covid-boblen og hertil. Der købes op til vanvittige værdiansættelser (heldigvis delvist ved brug af egne overprisede aktier) alt muligt, der passer til CEO’ens visioner - kører ind i en mur, når renterne stiger, og nu frasælges de samme opkøb.

Lad os vække denne tråd til live igen. Bicos 2024-resultat er kommet ud, og efter et par års ørkenvandring ser det faktisk ret godt ud. Tabet er reduceret markant siden 2023, og Q4/2024 har været et profitabelt kvartal.   Kilde: https://bico.com/investors/ Hvis nogen stadig er med, kan turen stadig blive meget bedre herfra. Dette slår helt sikkert Hesulin =)

Denne nyhed fra starten af juli var ikke blevet lagt herind endnu: Næste skridt i Sartorius-partnerskabet afsluttet: Flere delsalgs- og distributionsaftaler samt aftaler om R&D-projekter er blevet underskrevet                   BICO              Single Press release    BICO enables and automates the life science lab of the future.         Est. reading time: 1 minute                               De har altså indgået aftaler med Sartorius i maj-juni, og som følge heraf er aktiekursen steget med +30 % siden starten af juni.

Dagens industri – 7 Jun 23              Kraschrisk i medicinteknikbolaget    Ensidigt fokus på tillväxt på bekostnad av den finansiella stabiliteten fick Viaplay- och SBB-aktierna på fall och tvingade bort bolagens vd:ar.                             Her er der tilsyneladende noget om Bico, men det er kun synligt for abonnenter.

BICO              Single Press release    BICO enables and automates the life science lab of the future.         Est. reading time: 1 minute                               Årsregnskab offentliggjort kl. 7.00. Interessant at se, hvad markedet mener.

Holy shit. Kl. 10 er der lagt op til en røvfuld…

BICO Group

Redeye’s analyst just published a Research Update on BICO.Click here to read the articleMake sure to add BICO to your Watchlist at Redeye and our analysts will notify you if anything relevant...

<div class="mfn-body"><p>Redeye’s analyst just published a Research Update on BICO.</p><p><strong><a rel="noopener" href="https://www.redeye.se/research/1151833/bico-q4-review-improving-outlook-trading-at-ev-s-2026e-1x?utm_source=MFN&amp;utm_medium=pmcour">Click here to read the article</a></strong></p><p>Make sure to add BICO to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.</p><p>This is a press release from Redeye - Research Powered Investment Banking.&nbsp;<a rel="noopener" href="http://www.redeye.se/">www.redeye.se</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/fc3eac1e-ef52-4151-a709-6abe9e6e28ba/bico-q4-review-improving-outlook-and-trades-at-1x-sales.pdf" class="mfn-generated mfn-primary">BICO (Q4 review): Improving outlook and trades at &lt;1x sales</a></p></div>